Skip to main content
. 2016 Jun 18;22:2086–2096. doi: 10.12659/MSM.895390

Table 1.

Baseline characteristics and methodological quality of all included studies.

First author Year Ethnicity Disease Number Gender (M/F) Age (years) Genotype method Gene SNP NOS score
Case Control Case Control Case Control
Papagianni A [30] 2013 Caucasians Children 53 45 26/27 5.9±3.9 PCR-RFLP CD16 158 F>V 6
Nourse JP [29] 2012 Caucasians Total 100 100 51 (18~85) 39 (21~66) AS-PCR CD16 158 F>V 6
Eyada TK [20] 2012 Africans Children 92 90 44/48 40/50 8.3±4.5 6.2±3.5 PCR-RFLP CD16 131 H>R 8
AS-PCR CD16 158 F>V
Amorim DM [10] 2012 Caucasians Children 39 78 18/21 36/42 7.3±3.2 5.4±4.0 PCR-RFLP CD16 158 F>V 7
131 H>R
Breunis WB [21] 2008 Caucasians Adult 44 100 7/37 MLPA assay CD32 131 H>R 6
Children 72 100 35/37 MLPA assay CD32 131 H>R 6
Wang JH [31] 2007 Asians Total 74 111 22/52 45/66 34.5±13.3 39.0±16.3 AS-PCR CD16 158 F>V 7
Carcao MD [26] 2003 Caucasians Children 98 130 46/52 0.5±16.9 PCR-RFLP CD32 158 F>V 8
131 H>R
Fujimoto TT [27] 2001 Asians Total 104 59 28/76 30/29 26 54.2 PCR-RFLP CD32 158 F>V 8
131 H>R
Foster CB [22] 2001 Caucasians Children/chronic 36 218 PCR-RFLP CD32 158 F>V 6
131 H>R
Williams Y [32] 1998 Caucasians Total 29 61 30/60 10/19 7~75 20~55 AS-PCR CD32 131 H>R 6

M – male; F – female; SNP – single nucleotide polymorphism; NOS – Newcastle-Ottawa Scale; PCR-RFLP – polymerase chain reaction-restriction fragment length polymorphism; AS-PCR – allele-specific PCR, MLPA multiplex ligation-dependent probe amplification.